At Rocky Mountain Associated Physicians, we offer personalized, comprehensive medical weight loss led by a compassionate care team of nurse practitioners with advanced weight management training, board-certified obesity medicine physicians, registered dieticians and mental health specialists
On the other hand, the retrospective observational study by Jensen et al
Some protocols use 1 mL (5 mg/mL) or 2.5 mL (2 mg/mL)
RESULTS In this study, 7.5 mg of tirzepatide did not produce significant improvements in glycemic control or body weight after switching from 1.0 mg of semaglutide, while the 10 mg dose resulted in significant HbA1c reduction, but not significant weight loss
[PMID: 6526271] PubMed record related to this compound for laboratory literature review
Semaglutide Has an FDA Indication for MASH Wegovy received FDA accelerated approval for MASH (metabolic dysfunction-associated steatohepatitis) in August 2025